Why Is HilleVax (HLVX) Stock Down 87% Today?

InvestorPlace - Stock Market News, Stock Advice & Trading Tips

HilleVax stock is down on Monday after HLVX investors learned of a failed Phase 2b clinical trial of its norovirus vaccine for infants.

The post Why Is HilleVax (HLVX) Stock Down 87% Today? appeared first on InvestorPlace.

• The #1 AI Investment Might Be This Company You’ve Never Heard Of
• Musk’s “Project Omega” May Be Set to Mint New Millionaires. Here’s How to Get In.
• Legendary Investor Predicts: “Forget A.I. THIS Technology Is the Future”